FORGOTTEN HISTORY: 9 - Caught on Camera

CNBC's Final Trades: Interactive Brokers, Abbott Laboratories, Apple And This REIT Stock

On CNBC’s “Halftime Report Final Trades,” Joseph Terranova of Virtus Investment Partners chose Interactive Brokers Group, Inc. (NASDAQ: IBKR) as his top pick.

Benzinga · Mar 15, 2022

Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 3.32% on an annualized basis.

Benzinga · Mar 14, 2022

Abbott facing lawsuits, FDA investigation over recalled infant formula after reports of illness, death

Parents who bought recalled infant formulas made by Abbott Laboratories are filing proposed class-action lawsuits against Abbott, as the U.S. Food and Drug Administration investigates reports of three babies who became sick and two who died after consuming the formulas.

Chicago Tribune · Mar 2, 2022

Abbott Laboratories Whale Trades For January 26

Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Jan 26, 2022

Abbott Posts $2.3B In COVID-19 Test Sales In Q4; Issues FY22 Outlook

Abbott Laboratories (NYSE: ABT) has reported 

Benzinga · Jan 26, 2022

Recap: Abbott Laboratories Q4 Earnings

  Abbott Laboratories (NYSE:ABT) reported its Q4 earnings results on Wednesday, January 26, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga · Jan 26, 2022

A Preview Of Abbott Laboratories's Earnings

Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts estimate that Abbott Laboratories will likely report an Earnings Per Share (EPS) of $1.20.

Benzinga · Jan 25, 2022

CNBC's Final Trades: Abbott Laboratories, Starbucks, Bank of America And This Financial Services Stock

On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE: ABT) as her pick.

Benzinga · Jan 21, 2022

How Abbott Labs is crushing it in Asia

One secret to double-digit revenue growth: Low employee turnover.

Fortune · Apr 3, 2015